Rigol Technologies (688337) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
2 Oct, 2026Executive summary
FY2024 revenue rose 15.7% YoY to RMB775.8m, while net income fell 14.5% to RMB92.3m; stronger core-platform and solutions sales supported growth.
Gross margin improved 310 bps to 59.14%, but higher R&D and administrative spending and a one-off VAT input-tax reversal weighed on earnings.
Strategy is shifting toward high-end instruments and integrated solutions, reinforced by the full acquisition of Naisu Electronics and expanded R&D investment.
Financial highlights
FY2024 revenue was RMB775.8m, up 15.7% YoY; operating profit was RMB93.5m versus RMB114.6m in 2023.
Net income was RMB92.3m, down 14.5% YoY; adjusted for non-recurring items, net income was RMB58.3m, down 2.75%.
Q4 revenue was RMB240.9m and net income RMB32.2m; Q4 adjusted net income was RMB36.1m.
Operating cash flow turned positive at RMB117.5m from an outflow of RMB18.4m; investing cash outflow was RMB177.3m and financing cash inflow RMB201.3m.
A RMB16.0m VAT input-tax reversal at Beijing Rigol reduced FY attributable net income by an estimated RMB13.6m.
Outlook and guidance
2025 priorities include self-developed, high-end and platform-based products, with planned launches across instruments and solutions; no numerical revenue or earnings target was stated.
R&D plans focus on communications, new energy and semiconductors, modular instruments, platform software, microwave/RF technology, and development-center projects in Shanghai and Xi’an.
Market deployment plans include strengthening direct sales in developed markets and expanding local sales presence in Southeast Asia, South Asia and South America.
Plans include completing the Malaysia production-base buildout and pursuing strategic acquisitions aligned with the core testing-and-measurement business.
Latest events from Rigol Technologies
- Higher R&D and overhead cut H1 earnings despite improved gross margin.688337
Q2 2024 - Q3 growth and stronger margins contrast with lower 9M adjusted earnings.688337
Q3 2024 - Revenue grew, but higher R&D spending drove lower net income despite strong product growth.688337
Q1 2025 - High-end and solutions growth lifted sales, but non-recurring gains masked weak adjusted earnings.688337
Q2 2025 - Revenue grew, but higher costs and taxes cut adjusted earnings as solutions sales surged.688337
Q4 2025 - Revenue grew, but margin pressure and non-recurring gains masked a steep adjusted-profit decline.688337
Q3 2025 - Revenue rose 38% and net income 512%, while operating cash flow turned negative.688337
Q1 2026 - Strong sales growth, but earnings included non-recurring investment gains and cash flow stayed negative.688337
Q2 2026